The role of the liver histological and necroinflammatory activity in the development of portal hypertension syndrome.

Authors

  • I. Ya. Dzyubanovsky ДВНЗ «Тернопільський державний медичний університет імені І.Я.Горбачевського», Тернопіль, Ukraine
  • T. V. Romaniuk ДВНЗ «Тернопільський державний медичний університет імені І.Я.Горбачевського», Тернопіль, Ukraine
  • A. J. Hospodarskyy ДВНЗ «Тернопільський державний медичний університет імені І.Я.Горбачевського», Тернопіль, Ukraine
  • O. I. Slobodyanyuk ДВНЗ «Тернопільський державний медичний університет імені І.Я.Горбачевського», Тернопіль, Ukraine
  • A. Ye. Burak ДВНЗ «Тернопільський державний медичний університет імені І.Я.Горбачевського», Тернопіль, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2013.3.33-36

Keywords:

portal hypertension syndrome, diagnostic criteria, fibrotest, actitest, protein L-FABP

Abstract

Background. Liver cirrhosis is the most often cause of the portal hypertension syndrome development, though structural and morphological liver remodeling usually begins on the stage of chronic hepatitis. Morphologic patterns of the development of portal hypertension syndrome on the pre-clinical stage are still poorly investigated. Objective. To determine the histological and necroinflammatory activity of the liver in patients with portal hypertension. Methods. Patients were divided into four groups: I group (n=38) – chronic hepatitis without clinical signs of portal hypertension; II group (n=42) - chronic hepatitis transforming to cirrhosis with clinical signs of portal hypertension (varicose veins of the esophagus and/or the cardia, splenomegaly, ascitis); III group (n=34) – complicated portal hypertension on the background of liver cirrhosis (bleeding from the varices of the esophagus and/or the cardia, hypersplenism); control group (n=30) - physically healthy individuals aged 23-37 years. An integrated evaluation of the liver histological and necroinflammatory activity through the set of laboratory tests was performed (the method of “FibroTest-ActiTest”; immunofermental analysis of L-FABP concentration). Results. It is found that the patients with pre-clinical stage of portal hypertension syndrome show portal and periportal fibrosis with single septa, and the patients with clinical stages of portal hypertension show portal and periportal cirrhosis with multiple septa. Patients with the complications of portal hypertension show cirrhosis of the liver. With the increase of the necroinflammatory activity the portal pressure increases directly. This fact was confirmed with the increase of L-FABP protein level in the plasma, along with the increase of the actitest results. Conclusion. The diagnostic methodic of “FibroTest-ActiTest” and the plasma level of L-FABP are the modern models for chronic liver disease histological and necroinflammatory activity evaluation, though there is still the need to determine the correlation with the direct histological picture of liver biopsy.

References

  1. Горбашко А. И. Диагностика и лечение острых пищеводных кровотечений при циррозе печени и портальной гипертензии / А. И. Горбашко, Р. К. Рахманов // Спорные вопросы хирургического лечения портальной гипертензии у больных циррозом печени. – Ташкент, 1988. – С. 44-46.
  2. Gorbashko AI, Rakhmanov RK. [Diagnosis and treatment of acute esophageal bleeding in cirrhosis and portal hypertension]. In: [Controversial issues of portal hypertension surgical treatment in patients with liver cirrhosis. 6th Soviet Symposium; 1988; Tashkent]. Tashkent; 1988. p. 44-6. Russian.
  3. Buster E. H. Treatment of chronic hepatitis B virus infection – Dutch national guidelines / E. H. Buster , K. J. van Erpecum , S. W. Schalm et al. // Neth. J. Med. 2008. – Vol. 66, № 7. – P. 292–306.
  4. Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists. Treatment of chronic hepatitis B virus infection - Dutch national guidelines. Neth J Med. 2008 Jul-Aug;66(7):292-306. Cited in: PubMed; PMID: 18663260.
  5. Гарбузенко Д. В. Кровотечения из варикозно расширенных вен пищевода и желудка у больных циррозом печени: патогенез, профилактика, лечение / Д. В. Гарбузенко. – Челябинск: Издательский дом «Восточные Ворота», 2004. – 63 с.
  6. Garbuzenko DV. [Hemorrhage from varicose veins of the esophagus and the stomach in patients with liver cirrhosis: pathogenesis, prevention and treatment]. Chelyabinsk: Publishing House ‘Vostochnyye vorota’; 2004. 63 p. Russian.
  7. Апросина З. Г. Хронический активный гепатит как системное заболевание / З. Г. Апросина. – М.: Медицина, 1981. – 248 с.
  8. Aprosina ZG. Khronicheskiy aktivnyy gepatit kak sistemnoye zabolevaniye [Chronic active hepatitis as systemic disease]. Moscow: Meditsina; 1981. 248 p. Russian.
  9. Ивашкин В. Т. Лечение кровотечений, обусловленных портальной гипертензией / В. Т. Ивашкин, М. Ю. Надинская // Consilium medicum. 2001. – Т. 3, № 11. – С. 1–9.
  10. Ivashkin VT, Nadinskaya My. [Treatment of bleeding due to portal hypertension]. Consilium medicum. 2001; 3 (11): 1-9. Russian.
  11. Bernthal P. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance / P. Bernades, A. Hays, R. E. Tarter et al. // Hepatolo-gy. 1987. – Vol. 7. – P. 107 - 114.
  12. Bernthal P, Hays A, Tarter RE, Van Thiel D, Lecky J, Hegedus A. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology. 1987 Jan-Feb;7(1):107-14. Cited in: PubMed; PMID: 3804189.

Downloads

How to Cite

Dzyubanovsky, I. Y., Romaniuk, T. V., Hospodarskyy, A. J., Slobodyanyuk, O. I., & Burak, A. Y. (2013). The role of the liver histological and necroinflammatory activity in the development of portal hypertension syndrome. Морфологія / Morphologia / Morfologìâ, 7(3), 33–36. https://doi.org/10.26641/1997-9665.2013.3.33-36

Issue

Vol. 7 No. 3 (2013)

Section

Статті

License

Copyright (c) 2018 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.